SEMAGLUTIDE or TIRZEPATIDE
What's all the Hype about?

SEMAGLUTIDE & TIRZEPATIDE
Both are Revolutionary New Weight-Loss Medication

For decades, people have fought an uphill battle when it comes to weight-loss management. Adult obesity in the United States has nearly tripled from 13% in the 1960’s to 36% in 2009.  Struggling adults has often found that just changing their lifestyle and habits is insufficient in treating obesity but when combined with SEMAGLUTIDE or TIRZEPATIDE, weight loss can be achieved through a 2-prong approach. 

That’s why Hollywood Got Health offers several medical weight management solutions, including SEMAGLUTIDE or TIRZEPATIDE, which is the latest FDA-Approved Weight Loss Medication. Participants in a medical trial taking Semaglutide resulted in over 55% of the participants losing over 15% of their body weight. An additional 35% lost over 20% of their body weight.

A New Solution: What Is Semaglutide?

Originally used to treat Type-2 Diabetes, the FDA has recently approved SEMAGLUTIDE as a weight-loss aid and for long-term weight management as an adjunct to exercise and diet. Semaglutide is more commonly knows under the brand names Ozempic and Wegovy.

SEMAGLUTIDE is the first drug treatment to be FDA-approved for weight management in over 8 years. It’s part of a group of medications called glucagon-like peptide-1 (GLP-1) receptor agonists that balances out hormones such as insulin, which helps to regulate blood sugar. As a result, it potentially curbs appetites and allows you to lose weight because you eat less. In a recent study, patients took SEMAGLUTIDE weekly in conjunction with healthy lifestyle changes. The study group saw an average weight loss of -14.9%, a big difference compared to the placebo group, which averaged at -2.4%. In a 250 lb individual, that’s the difference between 37 lbs and 6 lbs!

SEMAGLUTIDE acts as an appetite suppressant by mimicking existing hormones that interact with our digestive system. SEMAGLUTIDE is a GLP-1 agonist, a type of hormone that limits how quickly your stomach empties food. By increasing these hormone levels, SEMAGLUTIDE keeps you feeling fuller, longer. This can help you limit your overall calorie consumption, aiding in weight loss.

Alternative: What Is Tirzepatide?

TIRZEPATIDE, more commonly knows under the brand name Mounjare, has garnered significant interest due to its potential for weight loss, due to its dual mechanism of action targeting both the GLP-1 and GIP receptors.

TIRZEPATIDE works by mimicking the GLP-1 and GIP hormones that are naturally secreted by the intestine after a meal, which prompts insulin secretion. It also reduces appetite by slowing down the time it takes the stomach to empty and interacting with areas in the brain harboring GLP-1 receptors to signal satiety. Instead of counting calories, TIRZEPATIDE helps a person eat less because it signals to the brain that you’re full,

Clinical trials on TIRZEPATIDE have shown participants treated with TIRZEPATIDE experienced significant reductions in body weight compared to those treated with other medications or placebo. Most participants lost an average of 20 percent of their body weight over 72 weeks for

Semaglutide vs Tirzepatide

TIRZEPATIDE and SEMAGLUTIDE are both medications used in the treatment of type 2 diabetes, belonging to the class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. While they share similarities, there are also some key differences between the two:

  1. Mechanism of Action:
    • TIRZEPATIDE: It is a dual agonist of both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. This means it activates both receptors to lower blood sugar levels and promote weight loss.
    • SEMAGLUTIDE: It selectively targets the GLP-1 receptor, stimulating insulin secretion and reducing glucagon secretion, which helps lower blood sugar levels and promotes weight loss.
  2. Weight Loss Efficacy:
    • Clinical trials have shown both TIRZEPATIDE and SEMAGLUTIDE to be effective in promoting weight loss in people with type 2 diabetes. TIRZEPATIDE has shown particularly robust weight loss effects, likely due to its dual receptor activation.
    • SEMAGLUTIDE has been studied in higher doses (up to 2.4 mg weekly) specifically for weight loss in people without diabetes. At these higher doses, SEMAGLUTIDE demonstrated significant weight loss in clinical trials.
  3. Dosage and Administration:
    • TIRZEPATIDE: It is typically administered once weekly via subcutaneous injection.
    • SEMAGLUTIDE: It is available in various formulations, including once-weekly and once-daily injections. Additionally, a higher-dose formulation of semaglutide (2.4 mg once weekly) is approved specifically for weight management in people without diabetes
  4. Clinical Trials:
    • Both TIRZEPATIDE and SEMAGLUTIDE have undergone extensive clinical trials to evaluate their efficacy and safety in people with type 2 diabetes.
    • TIRZEPATIDE has shown promising results in terms of reducing blood sugar levels, promoting weight loss, and potentially lowering the risk of cardiovascular events in clinical trials.
    • SEMAGLUTIDE has also demonstrated significant reductions in blood sugar levels, along with substantial weight loss effects in both diabetic and non-diabetic populations.

In summary, both TIRZEPATIDE and SEMAGLUTIDE are effective GLP-1 receptor agonists used for the treatment of type 2 diabetes and weight management. While TIRZEPATIDE offers the unique advantage of dual receptor activation, SEMAGLUTIDE has been studied at higher doses specifically for weight loss in non-diabetic individuals. The choice between the two medications may depend on individual patient factors, preferences, and clinical considerations, and should be made in consultation with a healthcare provider.

See If Semaglutide or Tirzepatide For Weight Loss Is Right for You

We understand the challenges and risks associated with a high body fat percentage can be overwhelming. When paired with healthy lifestyle changes, semaglutide is a great option to aid in your weight loss journey. While you cannot currently buy semaglutide online without a prescription, our team at Hollywood Got Health is ready to help you achieve a healthy lifestyle. Our certified medical professionals can assess if semaglutide is right for you and explore other possible medical weight loss solutions. Read what some of our happy customers have to say about working with us:
5/5

“At Hollywood Got Health, everything Alf suggested I use for weight loss has worked wonders for me. I have come off of all my previous medications that my doctor prescribed and have never felt better!”

— Jon E.

Our Patients Enjoy:

  • Convenient online consultations
  • VIP medical care from licensed physicians
  • High-touch customer service
  • Reliable access to prescriptions
  • Approval for HSA/FSA payments
  • Medically proven treatments and healthcare
  • Easy ordering with convenient home delivery

The Process Is Easy

1. Browse our treatment options.

At Hollywood Got Health, we offer a variety of treatment solutions for many different needs. We offer several options to treat hormone imbalance, as well as other solutions for weight loss, sexual enhancement, natural growth hormone stimulants and more.

2. Identify a treatment & schedule your consultation.

Once you’ve identified the treatment that’s right for your needs, schedule your consultation with one of our confidential and discreet licensed physicians. Need help deciding? We’re here to guide you to the right solution.

3. Consult online and get treatments shipped to your door.

Consult with a licensed physician from the comfort and convenience of your own home. From there, easily place your order and have your medications shipped directly to you. It’s that easy!

Ready to Get Started?

If you’re ready to get started on SEMAGLUTIDE or TIRZEPATIDE, please fill out the  form below. Upon completion, our staff will contact you to answer any additional questions you may have and setup an consultation with our Doctor 

Name(Required)
This field is for validation purposes and should be left unchanged.